|
|
 | |  | | | Room-A | 08:30 - 10:30
PRESENT AND FUTURE IMPACT OF THE PUBLIC HEALTH POLICY ON THE TREATMENT OF CARDIAC ARRHYTHMIAS - SESSION I HEALTH CARE FUNDING |  | |  | | Goeree R.
Meeting decision maker needs in the face of uncertainty: how is coverage with evidence development useful for cardiac devices? |  |
| |  | |  |
| | | | Mantovani L. G.
The real cost of arrhythmias treatment in a national scenario | |
| | | | |
| | | | Beccagutti G.
The rationale behind treatment reimbursement and the actual discrepancies | |
| | | | |
| | | | Biot J. N.
The optimal method for devices acquisition | |
| | | | |
| | | | Paone S.
Cost-efficacy evaluation by health technology assessment | |
| | | | |
| |
11:00 - 13:00
PRESENT AND FUTURE IMPACT OF THE PUBLIC HEALTH POLICY ON THE TREATMENT OF CARDIAC ARRHYTHMIAS - SESSION II THE ROLE OF THE MEDICAL COMMUNITY | | | | | Kuck K. H.
Guidelines revision according to the financial restrictions: is it possible and ethically acceptable? | |
| | | | |
| | | | Proclemer A.
National, Continental World Registries to control the therapy clinical outcome and its real financial long term impact | |
| | | | |
| | | | Gulizia M.
Implementing the concept of the HTA and of clinical impact in the EP medical community | |
| | | | |
| | | | Cappato R.
Usefulness of National and International Medical Panels as counterparts for the Regulatory Authorities | |
| | | | |
| | | | El Sherif N.
Optimizing in and out-of-hospital treatments and patients follow-up to reduce costs maintaining patient's safety | |
| | | | |
| |
13:15 - 14:45
PRESENT AND FUTURE IMPACT OF THE PUBLIC HEALTH POLICY ON THE TREATMENT OF CARDIAC ARRHYTHMIAS - SESSION III STATE OF THE ART - JOINT SESSION WITH WORLD SOCIETY OF ARRHYTHMIAS | | |
15:00 - 17:00
PRESENT AND FUTURE IMPACT OF THE PUBLIC HEALTH POLICY ON THE TREATMENT OF CARDIAC ARRHYTHMIAS - SESSION IV - REDUCING COSTS BY APPROPRIATE DEVICE/SELECTION TECHNIQUE AND PATIENT FOLLOW-UP | | | | | Boriani G.
Cost efficacy of antitachy and minimal ventricular pacing algorithms |
| | | | |
| | | | Oto A.
Single, dual, triple chamber ICD for primary prevention: the right selection | |
| | | | |
| | | | Brachmann J.
Multiple algorithms to reduce ICD inappropriate shocks: efficient new technology to improve quality of life and reduce re-hospitalization |
| | | | |
| | | | De Filippo P.
Benefits of atrial fibrillation continuous monitoring by implanted devices | |
| | | | |
| | | | Gasparini M.
The appropriate device treatment for HF patients: the right selection among low and high voltage devices | |
| | | | |
| | | | Aquilani S.
MRI device full compatibility: impaction on patient's life | |
| | | | |
| | | | Augello G.
Wireless remote control of patient's with implanted devices: high patient's compliance and cost reduction | |
| | | | |
| |
17:30 - 19:30
OPENING CEREMONY - WELCOME ADDRESS | | |
|
| |  | |  |
| | | | | Room-B | 11:00 - 13:00
CARDIAC MAGNETIC RESONANCE IN ARRHYTHMIC DISEASES | | |
13:15 - 14:45
FREE PAPERS - ATRIAL FIBRILLATION CRYOABLATION | | | | | Bourier F.
3D-VISUALIZATION OF CRYO BALLOON CATHETERS IN BIPLANE FLUOROSCOPY TO SUPPORT PULMONARY VEIN ISOLATION | |
| | | | |
| | | | Arena G.
CRYOBALLOON ABLATION OF ATRIAL FIBRILLATION: COMPARISON OF 3 DIFFERENT APPROACHES IN A SINGLE CENTER EXPERIENCE | |
| | | | |
| | | | Kurzidim K.
LARGE ANTRAL PULMONARY VEIN ISOLATION BY COMBINED CRYO-BALLOON AND IRRIGATED RADIOFREQUENCY CATHETER ABLATION IN PATIENTS WITH PERSISTENT ATRIAL FIBRILLATION | |
| | | | |
| | | | Ottaviano L.
CRYOBALLOON ABLATION FOR ATRIAL FIBRILLATION GUIDED BY REAL-TIME THREE-DIMENSIONAL TRANSOESOPHAGEAL ECHOCARDIOGRAPHY | |
| | | | |
| | | | Domenichini G.
FEASIBILITY, EFFICACY AND EFFICIENCY OF SIMULTANEOUS PULMONARY VEIN ISOLATION AND RIGHT ATRIAL CAVOTRICUSPID ISTHMUS ABLATION USING CRYOTHERAPY |
| | | | |
| | | | Mengoni A.
CRYOABLATION AND PERIPROCEDURAL COMPLICATION: OUR EXPERIENCE | |
| | | | |
| |
15:00 - 17:00
DUTY-CYCLED PHASED RF: THE EVOLUTION OF RF ABLATION | | | | | Nardi S.
Procedural Best Practices: how do we optimize clinical outcomes? | |
| | | | |
| | | | Boersma L. V.
Phased RF World Wide Experience |
| | | | |
| | | | Hummel J. D.
Multi-electrode Phased RF ablation: evolution of the technology | |
| | | | |
| | | | Spitzer S.
Fulfilling the Promise: the benefits of the phased RF procedure to the clinician |
| | | | |
| |
|
| | | | |
| | | | | Room-C | 11:00 - 13:00
VAGAL STIMULATION IN ARRHYTHMIAS AND HEART FAILURE | | | | | Bakacs A.
The anatomic distribution of the vagal system | |
| | | | |
| | | | Neuzil P.
Role of vagal stimulation in heart failure patients | |
| | | | |
| | | | Rossi P.
Role of vagal stimulation in AF rate control | |
| | | | |
| | | | Lanza G. A.
Spinal cord stimulation for nefractory angina pectoris: state of the heart | |
| | | | |
| |
13:15 - 14:45
LUNCHEON PANEL - FEW WOMEN IN ELECTROPHYSIOLOGY SESSION ORGANIZED IN COOPERATION WITH THE WORLD SOCIETY OF ARRHYTHMIAS AND THE EPIC ALLIANCE | | | | | Poole J. E.
Global career choices in EP: the results of the EPIC Alliance survey | |
| | | | |
| | | | Ernst S.
How to encourage female doctors to specialize in electrophysiology? | |
| | | | |
| | | | Bongiorni M. G.
Should we reserve working and institutional positions only for female electrophysiologists? | |
| | | | |
| | | | Linde C.
Reflections on my career. Strategies how to succeed as a female in EP |
| | | | |
| |
15:00 - 17:00
PM/ICD PATIENTS WITH "BORDERLINE HAEMODYNAMIC" CONDITIONS: A NEW ROLE FOR PREVENTIVE CRT? | | | | | Rossi S.
How to manage paced patients with long PR interval? Pro Dual Chamber optimized solutions | |
| | | | |
| | | | Piacenti M.
How to manage paced patients with long PR interval? Pro preventive CRT | |
| | | | |
| | | | Klug D.
How to manage ICD indicated patients with borderline EF? Pro RV pacing minimization | |
| | | | |
| | | | Botto G. L.
How to manage ICD indicated patients with borderline EF? Pro preventive CRT | |
| | | | |
| |
|
| | | | |
| | | | | Room-D | 11:00 - 13:00
MINICOURSE - PHARMACOLOGICAL TREATMENT OF CARDIAC ARRHYTHMIAS: OLD AND NEW DRUGS AVAILABLE | | | | | Ducceschi V.
The optimal drug to cardiovert paroxysmal atrial fibrillation | |
| | | | |
| | | | Kantharia B. K.
The optimal drug to cardiovert paroxysmal atrial flutter |
| | | | |
| | | | Dora S. K.
Long term drug prevention of ventricular tachycardia recurrences | |
| | | | |
| | | | Bianchi F.
Long term drug prevention of ventricular fibrillation recurrences | |
| | | | |
| |
13:15 - 14:45
FREE PAPERS - CRT OUTCOME | | | | | Sedlacek K.
LOW QLV TO QRS RATIO IS A STRONG MORTALITY AND HEART TRANSPLANTATION PREDICTOR IN NON-RESPONDERS TO CRT | |
| | | | |
| | | | Vargiu S.
A NEW CARDIAC RESYNCHRONIZATION THERAPY RESPONDER DEFINITION TO PREDICT LONG TERM OUTCOME: LEFT VENTRICULAR EJECTION FRACTION 35% OVERCROSSING AT 1 YEAR FOLLOW-UP | |
| | | | |
| | | | Partigulova A.
EFFECTIVENESS OF CRT IN PATIENTS WITH CHF AND PERMANENT ATRIAL FIBRILLATION WHEN MAXIMUM PERCENTAGE OF BIVENTRICULAR PACING IS ACHIEVED | |
| | | | |
| | | | Minarik T.
PULMONARY VASCULAR RESISTENCE IN PATIENTS WITH SEVERE LEFT VENTRICULAR DYSFUNCTION | |
| | | | |
| | | | Azhari A.
MID-TERM FOLLOW UP OF CARDIAC RESYNCHRONIZATION THERAPY: COMPARISON OF ISCHEMIC AND NONISCHEMIC CARDIOMYOPATHY | |
| | | | |
| | | | Calovic Z.
ACUTE IMPROVEMENT IN LEFT VENTRICULAR FUNCTION AND MECHANICAL DYSSYNCHRONY WITH MULTISITE LEFT VENTRICULAR PACING IN CARDIAC RESYNCHRONIZATION THERAPY PATIENTS | |
| | | | |
| |
15:00 - 17:00
HOME MONITORING: FROM CLINICAL VALIDATION TO A WIDER ADOPTION | | | | | Ricci R. P.
Does Home Monitoring show a better efficiency to detect events versus standard in office approach? Lessons from the Home Guide clinical experience |
| | | | |
| | | | Waldo A.
Can early detection of AF in remote monitored devices optimize the strategy for stroke prevention? The IMPACT study | |
| | | | |
| | | | Padeletti L.
Can daily tracking of heart failure clinical markers through Home Monitoring achieve in time detection and management of heart failure worsening? | |
| | | | |
| | | | Della Bella P.
Best timing for VT ablation: the role of Home Monitoring to track risky patients and address open questions on the most appropriate therapy after ICD implant | |
| | | | |
| | | | Mabo P.
Home Monitoring in pacemaker population: what is the advantage? | |
| | | | |
| | | | Varma N.
Remote Monitoring from adoption to reimbursement: do we still need further data? |
| | | | |
| |
|
| | | | |
| | | | | Room-E | 11:00 - 13:00
MINICOURSE - CLINICAL MANAGEMENT OF VENTRICULAR TACHYARRHYTHMIAS: FROM DRUGS TO SURGERY | | | | | Pappalardo A.
Surface ECG clinical evaluation of sustained ventricular tachycardia | |
| | | | |
| | | | Aquilina O.
Selection and timing of transcatheter endocardial ablation |
| | | | |
| | | | Lavalle C.
Selection and timing of transcatheter epicardial ablation | |
| | | | |
| |
13:15 - 14:45
FREE PAPERS - ATRIAL FIBRILLATION DETECTION | | | | | Boersma L.
EVALUATION OF REDUCTION OF ASYMPTOMATIC CEREBRAL EMBOLISM (ERACE) |
| | | | |
| | | | Zoppo F.
IMPROVING ATRIAL FIBRILLATION DETECTION CAPABILITY BY WEB-BASED APPLICATIONS. THE MULTICENTRE ITALIAN AFINDER PROJECT |
| | | | |
| | | | Ching M. E.
ADEQUACY OF ANTICOAGULATION THERAPY IN ASIAN PATIENTS WITH ATRIAL FIBRILLATION | |
| | | | |
| | | | Cervellati D.
DETECTION OF ATRIAL FIBRILLATION IN PATIENTS WITH CRYPTOGENIC STROKE BY LONG-TERM MONITORING WITH AN IMPLANTABLE CARDIAC MONITOR | |
| | | | |
| | | | Piazzi E.
AMBULATORY ECG RECORDING VS IMPLANTABLE LOOP RECORDER IN DETECTION OF ATRIAL FIBRILLATION RECURRENCES AFTER PULMONARY VEINS ISOLATION | |
| | | | |
| | | | Lucci C.
USEFULNESS OF IMPLANTABLE CARDIAC MONITOR IN DETECTING ARRHYTHMIA EPISODES IN PATIENT WITH CRYPTOGENIC STROKE OR TRANSIENT ISCHEMIC ATTACK | |
| | | | |
| |
15:00 - 17:00
CARDIAC ARRHYTHMIAS LONG TERM CLINICAL OUTCOME: NATURAL HISTORY 25 YEARS LATER | | | | | Borbola J.
Untreated frequent and repetitive premature ventricular beats in normal hearts |
| | | | |
| | | | Buja G.
Severe and stable sinus bradycardia |
| | | | |
| | | | Jaswal A.
Bifascicular block below 50 years age | |
| | | | |
| |
|
| | | | |
| | | | | Room-F | 08:30 - 10:30
MANAGEMENT OF ARRHYTHMIA BY DEVICE THERAPY ? EXCHANGE EXPERIENCE BETWEEN CHINA AND EUROPE EXPERTS | | | | | Chen K.
Potential Role of Home Monitoring in Reducing Atrial Fibrillation Burden in Patients with Pacemakers ? a Chinese Multicenter Registration Study |
| | | | |
| | | | Yan J.
The integrity optimization of cardiac resynchronization therapy for chronic heart failure |
| | | | |
| | | | Pignalberi C.
Drug therapy optimization by Home Monitoring in PMK and ICD patients | |
| | | | |
| | | | Bonnemeier H.
Antiarrhythmic electrical therapy optimization by Home Monitoring in ICD patients | |
| | | | |
| | | | Wang F.
Home Monitoring remote control of Pacemaker, Implantable Cardioverter Defibrillator, and Cardiac Resynchronization Therapy patients in clinical practice | |
| | | | |
| |
11:00 - 13:00
DEBATABLE SENTENCES IN ATRIAL FIBRILLATION TREATMENT | | | | | Sharma G.
Asymptomatic permanent atrial fibrillation with prolonged nocturnal asystolic pauses should not be permanently paced | |
| | | | |
| | | | Manaka T.
True brady ? tachy syndrome should receive a pacemaker plus antiarrhythmic drugs as first option therapy, more than ablation | |
| | | | |
| | | | Cavaco D.
Downgrading DDD pacing modality to VVI at a low rate is much better than upgrading to biventricular pacing for DDD patients with atrial fibrillation, short QRS duration and heart failure caused by right ventricular pacing | |
| | | | |
| | | | Saksena S.
Dual site right atrial pacing should be always used in patients with sick sinus syndrome paroxysmal atrial fibrillation and prolonged interatrial conduction | |
| | | | |
| | | | Arora V.
Antitachy atrial pacing should be always available in patients paced because of sick sinus syndrome | |
| | | | |
| |
13:15 - 14:45
FREE PAPERS - ICD INTERVENTIONS | | | | | D'Onofrio A.
ICD MODELS PRESCRIPTION & CURRENT GUIDELINES: RESULTS FROM THE FIRST REGISTRY | |
| | | | |
| | | | Zanotto G.
THE FIRST FIRING AFTER ICD IMPLANTATION. FINDINGS FROM A REAL LIFE EXPERIENCE | |
| | | | |
| | | | Burazor I.
INCIDENCE AND CHARACTERISTICS OF INAPPROPRIATE IMPLANTABLE CARDIOVERTERDEFIBRILLATOR SHOCKS OUT OF CLINICAL TRIALS |
| | | | |
| | | | Turco P.
ASSOCIATION BETWEEN INDUCIBILITY OF VENTRICULAR ARRHYTHMIA AND TACHYARRHYTHMIA RECURRENCES IN PATIENTS WITH ICD FOR PRIMARY PREVENTION OF SCD: DATA FROM THE AURA STUDY | |
| | | | |
| | | | Schwab J.
CHARACTERISTICS OF VF EPISODES DETECTION SETTINGS IN ICD PATIENTS TRANSMITTED BY A NEW REMOTE MONITORING SYSTEM - FIRST RESULTS OF THE GERMAN CARELINK ANALYTICS DEVICE DA | |
| | | | |
| | | | Risi A.
YEARLY AND WEEKLY VARIATION OF PATIENT ACTIVITY ? AN ANALYSIS OF 836 PATIENTS WITH IMPLANTED DEVICES | |
| | | | |
| |
15:00 - 17:00
RELIABILITY OF TECHNOLOGY IN DEVICE USE | | | | | Luzzi G.
Leads performance and extractions issues | |
| | | | |
| | | | Verlato R.
Devices longevity: effects in clinical practice and health care system | |
| | | | |
| | | | Occhetta E.
Induction test in ICD and CRT-D recipients: is still necessary? | |
| | | | |
| | | | Mascioli G.
Management of recall related matters: deal with technology and patients concern | |
| | | | |
| | | | Vassilikos V. P.
Delivering appropriate therapies: new possibilities and ascertained handling | |
| | | | |
| |
|
| | | | |
| | | | | Room-G | 08:30 - 10:30
INTERNATIONAL FORUM ON ANTICOAGULATION - SESSION I DEBATED TOPICS IN ANTICOAGULATION | | | | | Capucci A.
Duration of paroxysmal AF episodes versus total AF burden: relationship to thromboembolic rate | |
| | | | |
| | | | Deneke T.
Silent Cerebral Embolism during Pulmonary Vein Isolation | |
| | | | |
| | | | Gulizia M.
The role of implantable, remotely controlled, loop recorder in the follow-up of AF asymptomatic patients | |
| | | | |
| | | | Colivicchi F.
Appropriate and non appropriate anticoagulation: a frequent cause of medico-legal debate | |
| | | | |
| |
11:00 - 13:00
INTERNATIONAL FORUM ON ANTICOAGULATION - SESSION II - THE NEW ERA OF ORAL ANTICOAGULATION | | | | | Kol A.
Anticoagulant drugs and their interaction with the coagulation chain | |
| | | | |
| | | | Levy S.
Evidence based effectiveness of Dabigatran | |
| | | | |
| | | | Pasquale G. Di
Dabigatran in Clinical Practice |
| | | | |
| | | | Annino L.
Should thrombin inhibitors be the first choice drugs for oral anticoagulation? | |
| | | | |
| |
13:15 - 14:45
FREE PAPERS - CLINICAL PACING | | | | | Stazi F.
EFFICACY OF AAISAFE AND MVP STIMULATION TO MINIMIZE THE PERCENTAGE OF RIGHT VENTRICULAR PACING IN ICD PATIENTS | |
| | | | |
| | | | Laplante L.
ARE PACEMAKERS WITHHOLDING THE DIAGNOSIS OF ATRIAL FIBRILLATION IN HIGHLY DEPENDENT PACEMAKER PATIENTS ? | |
| | | | |
| | | | Botto G.
MANAGED VENTRICULAR PACING COMPARED TO CONVENTIONAL DUAL-CHAMBER PACING FOR ELECTIVE REPLACEMENT IN CHRONICALLY PACED PATIENTS: RESULTS OF THE PREFER MVP RANDOMIZED STUDY | |
| | | | |
| | | | Ricciardi G.
CYSTATIN C AND RESPONSE TO CARDIAC RESYNCHRONIZATION THERAPY |
| | | | |
| | | | Perrotta L.
EFFECTS OF SMOKING IN PATIENTS TREATED WITH CARDIAC RESYNCHRONIZATION THERAPY | |
| | | | |
| | | | Biffi M.
PERFORMANCE EVALUATION OF A RIGHT VENTRICULAR AND A RIGHT ATRIAL AUTOMATIC CAPTURE VERIFICATION ALGORITHM: THE ESSENTIAL REGISTRY | |
| | | | |
| |
15:00 - 17:00
15 YEARS OF INNOVATION IN ATRIAL FIBRILLATION AND HEART FAILURE TREATMENT: WHAT IS THE "NEXT BIG THING"? | | | | | Rinaldi C. A.
Innovative guidewire for a better biventricular stimulation: can it improve the patient outcome? |
| | | | |
| | | | Vicedomini G.
Innovative navigation system through the heart: which benefits for patients and physicians? | |
| | | | |
| | | | Perego G. B.
Innovative implantable haemodynamic sensor: a solution for the heart failure treatment optimization | |
| | | | |
| | | | Pappone C.
Innovative approach and technology to treat persistent and permanent atrial fibrillation | |
| | | | |
| | | | Betts T. R.
Innovative pacing: epicardial and endocardial left ventricular stimulation | |
| | | | |
| | | | Mantica M.
Atrial fibrillation & left atrial appendage closure: state of the art |
| | | | |
| |
|
| | | | |
| | | | | Room-H | 11:00 - 13:00
MINICOURSE - ELECTRICAL CARDIOVERSION OF ATRIAL FIBRILLATION. CLINICAL QUESTIONS IN THE DAILY PRACTICE - SESSION I | | | | | Colaiaco C.
High efficacy, safety and repeatability of transthoracic electrical cardioversion | |
| | | | |
| | | | Spaziani D.
Pre-cardioversion transesophageal echo: mandatory in all the patients? | |
| | | | |
| | | | Bokhari F.
Brain MRI pre and post cardioversion: what did we learn? | |
| | | | |
| | | | Ciudin R.
Acute pulmonary oedema early post-cardioversion: Why? How to avoid it? | |
| | | | |
| | | | Shenthar J.
Atrial stunning post cardioversion: should we monitor it? | |
| | | | |
| | | | Sarubbi B.
Electrical cardioversion in anticoagulated patients with stable thrombus: is it feasible? | |
| | | | |
| |
15:00 - 17:00
MINICOURSE - ELECTRICAL CARDIOVERSION OF ATRIAL FIBRILLATION. CLINICAL QUESTIONS IN THE DAILY PRACTICE - SESSION II | | | | | Petrac D.
Should we always perform a transesophageol echocardiogram before attempting cardioversion of atrial fibrillation? | |
| | | | |
| | | | Avella A.
Should intravenous antiarrhythmic treatment be always administrated only in hospital? | |
| | | | |
| | | | Santamaria M.
Should we treat paroxysmal atrial fibrillation in potentially pregnant women only by electrical cardioversion? | |
| | | | |
| | | | Setti S.
Could class 1C drugs be used intravenously without an echocardiographic control, in patients with paroxysmal atrial fibrillation haemodynamically well tolerated? | |
| | | | |
| | | | Santomauro M.
Should we always reprogram pacemaker output at high energy level before electrical cardioversion? | |
| | | | |
| | | | Uribe Arango W.
Should we use more "ablate and pace" in patients with post ablation recurrences of high rate atrial fibrillation? | |
| | | | |
| |
|
| | | | |
| | | | | Room-I | 15:00 - 17:00
FREE PAPERS - CRT IMPLANTATION TECHNIQUES | | | | | Malecka B.
CHANGES IN QRS WIDTH IN PTS WITH SURGICAL EPICARDIAL LV LEAD IMPLANTATION | |
| | | | |
| | | | Ricapito M.
MULTISLICE CARDIAC TOMOGRAPHY: A USEFUL TOOL BEFORE BIVENTRICULAR PACEMAKER IMPLANTATION | |
| | | | |
| | | | Sapelnikov O.
ISOLATED LEFT VENTRICULAR PACING AS ONE OF THE CHOICES OF SELECTIVE SITE PACING | |
| | | | |
| | | | Taieb J.
RESYNCHRONIZATION DEVICE IMPLANTATION PROCEDURE IN REAL LIFE. THE FRENCH ELECTRA SURVEY | |
| | | | |
| | | | Taieb J.
INTEREST OF A SIMPLE METHOD FOR CORONARY SINUS LEAD TUNNELING FROM CONTROLATERAL TO HOMOLATERAL SUBCLAVIAN VEIN IN UPGRADING INDICATIONS | |
| | | | |
| | | | Vado A.
SINGLE-CENTRE EXPERIENCE OF A QUADRIPOLAR PACING LEAD FOR CARDIAC RESYNCHRONIZATION THERAPY: RESULTS AFTER 3 MONTHS FROM IMPLANT | |
| | | | |
| |
|
| | | | |
| | | | | Room-A | 08:30 - 10:30
PHYSIOLOGICAL PACING. SCIENTIFIC EVIDENCE | | | | | Al Fagih A.
Should we avoid to pace the right ventricle as much as possible in all the patients? | |
| | | | |
| | | | Vincenti A.
Monitoring the reduction in right ventricular pacing by remote control in heart failure patients | |
| | | | |
| | | | Molon G.
Antitachy atrial pacing linked to minimal ventricular pacing algorithms improves clinical outcome | |
| | | | |
| | | | Ciaramitaro G.
Limiting right ventricular pacing decreases the incidence of atrial fibrillation and stroke | |
| | | | |
| | | | Saksena S.
Indication and benefits of dual site right atrial pacing | |
| | | | |
| |
11:00 - 13:00
PATIENT ACCESS TO DEVICE THERAPY: HOW CAN NEW TECHNOLOGIES HELP TO PROVIDE ALL PATIENTS WITH THE TAILORED THERAPY? | | | | | Bauer W.
MRI in pacemaker population: an option for all patients? | |
| | | | |
| | | | Santini L.
MRI and ICD population: what impact and what expectation? | |
| | | | |
| | | | Biffi M.
Longevity of implantable device: what impact in the long term patient outcome? | |
| | | | |
| | | | Vogtmann T.
Home Monitoring and worldwide adoption: is it already changing clinical practice? | |
| | | | |
| | | | Maglia G.
Single chamber ICD with atrial sensing: is it a simple and effective way to address patients with primary prevention indications? | |
| | | | |
| |
13:15 - 14:45
LUNCHEON PANEL - HIGH VOLTAGE LEADS MANAGEMENT: FACTS VS FICTION | | | | | Fischer A.
High voltage leads troubles: how to evaluate them correctly? | |
| | | | |
| | | | Padeletti L.
Final Remarks |
| | | | |
| |
15:00 - 17:00
MANAGING IMPLANTABLE DEVICES AND LEAD FAILURES IDENTIFIED BY REMOTE CONTROL | | | | | Luderitz B.
Different level of importance according to the type of malfunction and patient's characteristics | |
| | | | |
| | | | Soldati E.
Lead failure early identification and management | |
| | | | |
| | | | Quesada A.
Devices failure early identification and management | |
| | | | |
| | | | Steinhaus D. M.
How should a company deal with product reliability and product recalls? | |
| | | | |
| | | | Kennergren C.
Explantation of failing implantable leads and devices: decision making | |
| | | | |
| | | | Boriani G.
The value of International registries in the early identification of failing products |
| | | | |
| |
17:30 - 19:00
FREE PAPERS - PACING LEADS TROUBLES AND TROUBLESHOOTING | | | | | Malecka B.
LATE CHANGES IN ELECTRICAL IMPEDANCE AS A PRELIMINARY SIGN OF ENDOCARDIAL LEAD DAMAGE | |
| | | | |
| | | | Tomaszewski A.
ECHOCARDIOGRAPHIC DIAGNOSIS OF HEART WALL PERFORATION DUE TO PM AND ICD LEADS |
| | | | |
| | | | Amador P.
RIATA AND RIATA ST LEAD DAMAGE IN A CENTER IN PORTUGAL: PREVALENCE AND DECISIONS ACCORDING TO GENERATOR FAMILY | |
| | | | |
| | | | Kutarski A.
TRANSVENOUS EXTRACTION OF 1989 PERMANENTLY IMPLANTED LEADS IN 1171 PTS. USING MECHANICAL SYSTEMS - EFFECTIVENESS AND COMPLICATIONS | |
| | | | |
| | | | Chudzik M.
ENDOCARDIAL LEADS EXTRACTION ? 5 YEARS OF EXPERIENCE, POLISH REGISTRY | |
| | | | |
| | | | Vado A.
SINGLE-CENTRE EXPERIENCE OF POWER TOOL FOR LEAD EXTRACTION | |
| | | | |
| |
|
| | | | |
| | | | | Room-B | 08:30 - 10:30
CRYOBALLOON ABLATION OF ATRIAL FIBRILLATION - SESSION I - REDEFINING PULMONARY VEIN ISOLATION | | | | | Vogt J.
Best practices using cryoballoon ablation |
| | | | |
| | | | Gallagher M.
Procedural evolution: integration of a circular mapping catheter | |
| | | | |
| | | | Straube F.
What are we learning from real time recording of PV signals during cryoablation? |
| | | | |
| | | | Chun K. R. J.
How to treat challenging anatomies |
| | | | |
| | | | Tondo C.
Arctic Front advance: early experience | |
| | | | |
| |
11:00 - 13:00
CRYOBALLOON ABLATION OF ATRIAL FIBRILLATION - SESSION II - THE NEW STANDARD OF CARE FOR PVI? | | | | | Guerra P.
Arctic Front: global clinical experience | |
| | | | |
| | | | Neumann T.
Cryoballoon ablation of pulmonary veins: what are the long terms results? | |
| | | | |
| | | | Schilling R.
Arctic Front vs. radiofrequency ablation for paroxysmal atrial fibrillation: randomized single center experience |
| | | | |
| | | | Kuck K. H.
Fire and Ice: prospective randomized comparison of cryoballoon ablation vs. thermocool | |
| | | | |
| | | | Klein G.
Cost-effectiveness analysis of PVI using the cryoballoon: a high-value procedure for payers? | |
| | | | |
| |
13:15 - 14:45
CRYOBALLOON ABLATION OF ATRIAL FIBRILLATION - SESSION III - CLINICAL CASE PRESENTATIONS | | | | | Pandozi C.
Assessment of pulmonary vein isolation during the cryoballoon procedure | |
| | | | |
| | | | Fassini G. M.
Cryoballoon ablation strategy in patients with persistent atrial fibrillation | |
| | | | |
| | | | Senatore G.
Occlusion strategies with the cryoballoon in common ostia | |
| | | | |
| | | | Deharo J. C.
Occlusion strategies with the cryoballoon in challenging anatomies | |
| | | | |
| |
15:00 - 17:00
STANDARD OF CARE IN CRT: HOW TO REDUCE ADVERSE EVENT AND IMPROVE PATIENT OUTCOME | | | | | Gras D.
Difficulties to reach LV free wall: is still an issue? | |
| | | | |
| | | | Mantovan R.
Technical troubles and potential troubleshooting in CRT Patients | |
| | | | |
| | | | Thibault B.
Multipolar left ventricular lead: long term worldwide experience | |
| | | | |
| | | | Giannola G.
Perspectives in multipolar left ventricle pacing | |
| | | | |
| | | | Senatore G.
CRT patient outcome improvement by remote control | |
| | | | |
| |
17:30 - 19:00
FREE PAPERS - CATHETER ABLATION OF VENTRICULAR TACHYCARDIA | | | | | Soldati E.
EFFECTIVENESS OF IMAGE- INTEGRATION USING INTRACARDIAC ECHOGRAPHY AND ELECTROANATOMIC MAPPING IN ABLATION OF VENTRICULAR ARRHYTHMIAS | |
| | | | |
| | | | Scopinaro A.
LEFT VENTRICULAR ULTRA HIGH DENSITY MAPPAGE PERFORMED BY CIRCULAR DUODECAPOLAR CATHETER FEASIBILITY, SAFETY AND EFFICACY | |
| | | | |
| | | | Scopinaro A.
VENTRICULAR TRANSMURAL BIPOLAR SIGNAL (TBS) MAPPING | |
| | | | |
| | | | Malaspina D.
IS ALWAYS VENTRICULAR FASCICULAR TACHYCARDIA (FT) A BENIGN CONDITION? | |
| | | | |
| | | | Rizkallah J.
SUCCESSFUL ABLATION OF IDIOPATHIC LEFT VENTRICULAR TACHYCARDIA IN AN ADULT PATIENT ON ECMO |
| | | | |
| |
|
| | | | |
| | | | | Room-C | 08:30 - 10:30
STROKE PREVENTION BY NEW IMPLANTABLE TECHNOLOGY | | | | | Grossi S.
Trouble and troubleshooting |
| | | | |
| |
11:00 - 13:00
PATIENT MANAGEMENT IN THE REMOTE MONITORING ERA | | | | | Senatore G.
Remote patient monitoring is useful in all patients? | |
| | | | |
| | | | Aliot E.
Pharmacological management through remote approach: real effectiveness? | |
| | | | |
| | | | Perego G. B.
Multisensors approaches in patient's global management | |
| | | | |
| | | | Benditt D. G.
Sensors and other remote tool for patients not yet implanted | |
| | | | |
| | | | Gramegna L.
Social and economical sustainability of remote patient's management: the Italian point of view | |
| | | | |
| | | | Merkely B.
Social and economical sustainability of remote patient's management: the European point of view | |
| | | | |
| |
13:15 - 14:45
LUNCHEON PANEL - MANAGEMENT OF ACUTE-DECOMPENSATED HEART FAILURE WITH FLUID OVERLOAD SYNDROME: ULTRAFILTRATION? | | | | | Ronco C.
The role of cardiorenal syndrome in acute-decompensated patient |
| | | | |
| | | | Aspromonte N.
Ultrafiltration looking for the proper patient |
| | | | |
| |
15:00 - 17:00
ENDOCAVITARY ELECTRICAL CARDIOVERSION | | | | | Santini L.
Available materials and techniques: totally intracavitary, hybrid, high energy, low energy | |
| | | | |
| | | | Chakraborty R.
Need for shock contemporary synchronization on P and R wave | |
| | | | |
| | | | Ficili S.
Can high frequency antitachy pacing facilitate endocavitary cardioversion? | |
| | | | |
| | | | Lavalle C.
How painful it is? Threshold-pain relationship | |
| | | | |
| |
17:30 - 19:00
FREE PAPERS - ICD PERFORMANCE | | | | | Toennis T.
PREDICTION OF VENTRICULAR ARRYTHMIAS BY QRS-FRAGMENTATION DETECTED WITH MAGNETIC FIELD IMAGING (MFI) AMONG PATIENTS WITH PRIMARY PREVENTIVE ICD-INDICATION | |
| | | | |
| | | | Menardi E.
THE ROLE OF NT-PROBNP IN THE RISK STRATIFICATION OF ISCHAEMIC PATIENTS WITH IMPLANTABLE CARDIOVERTER DEFIBRILLATORS: RESULTS FROM THE CAMI-GUIDE STUDY | |
| | | | |
| | | | Schilling R.
RATE OF CHANGE IN RESPIRATORY RATE IS SIGNIFICANTLY HIGHER IN PATIENTS WITH HF EVENTS THAN PATIENTS WITHOUT HF EVENTS | |
| | | | |
| | | | Verlato R.
CLINICAL OUTCOMES IN PATIENTS WITH IMPLANTABLE CARDIOVERTER DEFIBRILLATORS AND SPRINT FIDELIS LEADS | |
| | | | |
| | | | Segreti L.
ST JUDE - RIATA LEAD EXTRACTION IN A HIGH VOLUME CENTRE |
| | | | |
| |
|
| | | | |
| | | | | Room-D | 17:30 - 19:00
FREE PAPERS - REMOTE MONITORING IN HEART FAILURE | | | | | Rocca P.
REMOTE MONITORING IN THE REAL WORLD:THE IMPACT OF ICD/CRTD DEVICES ON PHARMACOLOGICAL TREATMENT IN HEART FAILURE PATIENTS. A SINGLE CENTRE EXPERIENCE | |
| | | | |
| | | | Luzi M.
REMOTE MONITORING FOR IMPLANTABLE DEFIBRILLATORS: THE NATION-WIDE ITALIA-RPM SURVEY | |
| | | | |
| | | | De Simone A.
REMOTE PATIENT MANAGEMENT IN PATIENTS WITH HEART FAILURE: DATA FROM EFFECT STUDY | |
| | | | |
| | | | Schwab J.
PROPERTIES OF VF THERAPIES IN ICD PATIENTS TRANSMITTED BY A NEW REMOTE MONITORING SYSTEM - FIRST RESULTS OF THE GERMAN CARELINK ANALYTICS DEVICE DATABASE | |
| | | | |
| | | | Rocca P.
RESPIRATE PROJECT: THE HF PATIENT'S CO-MANAGEMENT BETWEEN HF SPECIALIST AND GENERAL PRACTITIONER | |
| | | | |
| | | | Caputo M.
COST-BENEFIT ANALYSIS IN PATIENTS WITH REMOTE MONITORING IN THE SIENA AREA | |
| | | | |
| |
|
| | | | |
| | | | | Room-E | 08:30 - 10:30
GLOBAL ARRHYTHMIA FORUM (GAF) SESSION I - CURRENT STATUS AND DEBATABLE TOPICS ON CARDIAC PACING - JOINT SESSION WSA-CSPE | | | | | Padeletti L.
Current Indications to single and dual chamber pacing in Europe | |
| | | | |
| | | | Zou J.
Current Indications to single and dual chamber pacing in China |
| | | | |
| | | | Su Y.
Ventricular pacing site selection and outlook in the future in China | |
| | | | |
| | | | Hua W.
Current status and future development of device therapy in China | |
| | | | |
| | | | Aliot E.
ICD for Primary Prevention of Sudden Death in Europe | |
| | | | |
| | | | Hua W.
ICD for Primary Prevention of Sudden Death in China | |
| | | | |
| |
11:00 - 13:00
GLOBAL ARRHYTHMIA FORUM (GAF) SESSION II - REMOTE MONITORING AND CASE STUDY - JOINT SESSION WSA-CSPE | | | | | Chen K.
Device Remote Monitoring in China: state of the art | |
| | | | |
| | | | Sutton R.
Benefits of Remote Monitoring in arrhythmia control | |
| | | | |
| | | | Lau C. P.
Benefits of Remote Monitoring in heart failure treatment |
| | | | |
| | | | Quesada A.
Benefits of Remote Monitoring in lead performance follow-up | |
| | | | |
| | | | Fisher J. D.
Should MRI and remote control be mandatory for all the new implants? | |
| | | | |
| |
13:15 - 14:45
FREE PAPERS - SPECIAL TECHNIQUES | | | | | Vitali Serdoz L.
PACE-MAKER IMPLANTATION AFTER TAVI PROCEDURES, A SINGLE CENTER EXPERIENCE | |
| | | | |
| | | | Pelissero E.
LEFT ATRIAL APPENDAGE CLOSURE WITH WATCHMAN DEVICE: INITIAL SINGLE CENTRE EXPERIENCE |
| | | | |
| | | | Kutarski A.
HEART WALL PERFORATION WITH ENDOCARDIAL LEAD ? SYMPTOMS & DIAGNOSTICS | |
| | | | |
| | | | Schirripa V.
THE USE OF REMOTE MONITORING SYSTEM LATITUDE® WITH EXTERNAL BODY WEIGHT AND BLOOD PRESSURE SENSORS: CRT-D VS ICD | |
| | | | |
| |
15:00 - 17:00
ENDOCAVITARY MAPPING AND ELECTRICAL CARDIOVERSION OF ATRIAL FIBRILLATION | | | | | Romano V.
Mapping AF onset and modifications in right and left atrium | |
| | | | |
| | | | Sgueglia M.
Prevention of atrial fibrillation onset by pacing algorithms: is it really effective? | |
| | | | |
| | | | Themistoclakis S.
Differences in endocavitary mapping between spontaneous and induced atrial fibrillation | |
| | | | |
| | | | Nabar A.
Low energy endocavitary cardioversion of atrial fibrillation: what's new? | |
| | | | |
| | | | Di Biase L.
Right atrium capture by high rate pacing during atrial fibrillation | |
| | | | |
| |
17:30 - 19:00
FREE PAPERS - CARDIAC ARRHYTHMIAS: CLINICAL ISSUES | | | | | Ferrero P.
PROSPECTIVE EVALUATION OF A STANDARDISED PROTOCOL TO MANAGE CONDUCTION DISORDERS IN HOCM PATIENTS UNDERGOING EXTENDED MYECTOMY: A SINGLE CENTRE EXPERIENCE |
| | | | |
| | | | Gallagher M.
THE VENTRICULAR ECTOPIC QS INTERVAL (VEQSI): A POTENTIAL MARKER FOR VENTRICULAR ARRHYTHMIA IN ISCHAEMIC HEART DISEASE | |
| | | | |
| | | | Proietti R.
REMOTE MAGNETIC WITH OPEN-IRRIGATED CATHETER VERSUS MANUAL NAVIGATION FOR ABLATION OF ATRIAL FIBRILLATION: A SYSTEMATIC REVIEW | |
| | | | |
| | | | Della Rocca D.
A MULTICENTRIC CLINICAL STUDY FOR PREDICTIVE VALUE ASSESSMENT OF RESPIRATORY RATE TREND (RRT) IN A POPULATION OF DEVICE-IMPLANTED PATIENTS WITH CHRONIC HEART FAILURE (MULTITUDE-HF): STUDY DESIGN AND POPULATION COMPOSITION | |
| | | | |
| | | | Kilicaslan F.
PROLONGED TP-E INTERVAL, TP-E/QT RATIO AND TP-E/QTC RATIO IN PATIENTS WITH TYPE 2 DIABETES MELLITUS | |
| | | | |
| |
|
| | | | |
| | | | | Room-F | 08:30 - 10:30
DEBATABLE SENTENCES IN VENTRICULAR TACHYCARDIA TREATMENT | | | | | Tola G.
Early post-infarction unsustained ventricular tachycardia should be investigated by premature ventricular stimulation also in patients with normal ejection fraction | |
| | | | |
| | | | Carbucicchio C.
Sustained ventricular tachycardia ablation should be always performed concomitant to ICD implantation | |
| | | | |
| | | | D'Onofrio A.
Biventricular is superior to isolated right ventricular antitachy pacing to stop ventricular tachycardias | |
| | | | |
| | | | Naik A.
Electrical storm predicts short patient's survival | |
| | | | |
| |
11:00 - 13:00
MODERN IMPLANTABLE DIAGNOSTIC TOOLS REMOTELY CONTROLLED | | | | | Brignole M.
Implantable loop recorder as first option in the diagnostic flow chart of syncope (The Issue III Trial) | |
| | | | |
| | | | Vanoli E.
Arrhythmia detection by ILR in patients with limited reduction of cardiac contractility (The Carrying On Study) | |
| | | | |
| | | | Ruiz Granell R.
ILR to reduce the stroke rate in patients with paroxysmal AF | |
| | | | |
| | | | Senatore G.
Clinical impact of implantable monitors after atrial fibrillation ablation | |
| | | | |
| | | | Rovaris G.
Remote control improves significantly the clinical outcome of patients with ILR | |
| | | | |
| | | | Ammirati F.
Cost benefit ratio of ILR provided by remote control | |
| | | | |
| |
15:00 - 17:00
HEART FAILURE AND CARDIAC ARRHYTHMIAS: CLINICAL ISSUES | | | | | Molina L. G.
Relationship between atrial fibrillation and heart failure: therapeutical consequences | |
| | | | |
| | | | Eslami M.
How to manage non sustained and sustained ventricular tachyarrhythmias in heart failure patients | |
| | | | |
| | | | Karmelic Serrano C.
Malignant arrhythmias in the setting of acute coronary syndromes: how to evaluate and to manage them? | |
| | | | |
| | | | Paraskevaidis S.
Indications to ICD implant in patients with heart failure and advanced chronic renal insufficiency | |
| | | | |
| | | | Pierantozzi A.
Heart failure deterioration and electrical storm: which comes first? |
| | | | |
| |
17:30 - 19:00
FREE PAPERS - IMPLANTABLE LOOP RECORDER | | | | | Rafanelli M.
USEFULNESS OF INSERTABLE CARDIAC MONITOR IN OLDER PATIENTS WITH UNEXPLAINED FALL AFTER A COMPLETE NEUROAUTONOMIC EVALUATION | |
| | | | |
| | | | Ungar A.
THE ROLE OF CONTINUOUS MONITORING AND ATRIAL FIBRILLATION IN SYNCOPE PATIENTS | |
| | | | |
| | | | Molon G.
THE PROJECT SINCOPE IN TRIVENETO (PROSIT) STUDY. A MULTICENTER STUDY REGARDING SYNCOPE MANAGEMENT IN AN ITALIAN REGION | |
| | | | |
| | | | Tomaino M.
DUAL CHAMBER PACEMAKER WITH RATE DROP RESPONSE ALGORITHM IN PATIENTS WITH SEVERE CLINICAL PRESENTATION OF NEURALLY-MEDIATED SYNCOPE SELECTED BY IMPLANTABLE LOOP RECORDER | |
| | | | |
| | | | Locati E.
DIAGNOSIS OF INFREQUENT ARRHYTHMIC EVENTS BY A NEW HIGH-CAPACITY MEMORY EXTERNAL LOOP RECORDER: TOWARDS AN EXTENDED HOLTER MONITORING |
| | | | |
| | | | Losik D.
DOES AF BURDEN MEASURED BY IMPLANTABLE LOOP RECORDER DURING POST-ABLATION BLANKING PERIOD PREDICT RESPONSE AT 12 MONTH FOLLOW-UP? | |
| | | | |
| |
|
| | | | |
| | | | | Room-G | 08:30 - 10:30
NEWS ON ATRIAL FIBRILLATION THERAPY | | | | | Savelieva I.
Stroke prevention: which warfarin alternative to select? |
| | | | |
| | | | Abboud J.
When should we give up on sinus rhythm? | |
| | | | |
| | | | Pozzolini A.
Vernakalant: a new antiarrhythmic drug to stop and to prevent atrial fibrillation | |
| | | | |
| | | | Bianchi S.
The role of vagal stimulation to reduce ventricular rate |
| | | | |
| | | | Muneretto C.
Endoscopic surgical ablation: how, when, results? | |
| | | | |
| | | | Peters N. S.
Review of surgical and hybrid ablation for the treatment of lone AF patients: experiences and opportunities | |
| | | | |
| |
11:00 - 13:00
HAEMODYNAMIC REGULATION OF CARDIAC PACING THROUGH THE TVI SENSOR: APPLICATIONS IN CLINICAL PRACTICE | | | | | Padeletti L.
Haemodynamic value of TVI sensing assessed in an experimental model | |
| | | | |
| | | | Calvi V.
Reliability and clinical benefit of TVI-based ejection check | |
| | | | |
| | | | Neri G.
Right-ventricular pacing prevention and timing | |
| | | | |
| | | | Fedorco M.
TVI recording on implantationcan drive the selection of the pacing site | |
| | | | |
| | | | Dorticos F.
Long-term haemodynamic surveillance of pacemaker patients | |
| | | | |
| |
13:15 - 14:45
LUNCHEON PANEL - STEM CELLS AND CARDIAC ARRHYTHMIAS | | | | | Perrone G. A.
Atrial stem cells in patients with atrial fibrillation |
| | | | |
| | | | Mocini D.
Pericardial fluid: a carrier for cardiac cell communication | |
| | | | |
| | | | Lewalter T.
Stem cell treatment for ischemic ventricular tachycardia |
| | | | |
| |
15:00 - 17:00
BREAKTHROUGH INNOVATION IN HEALTH CARE | | | | | Morgan J.
Challenges in healthcare: how to maximize the benefits of medical devices within the limits of the available resources? | |
| | | | |
| | | | Biffi M.
A new, reinvigorated approach to purchase and manage medical devices | |
| | | | |
| | | | Bonnemeier H.
Technical assistance in situ during ICD implants: need or habit? |
| | | | |
| | | | Tubertini M.
Increasing hospital efficiency is a priority today. How can we make it happen? | |
| | | | |
| | | | Tritto M.
How to harmonize the device selection for different patients in various geographic areas without reducing the quality of treatment? | |
| | | | |
| | | | Ascione R.
The impact of web technologies in healthcare: the future scenario | |
| | | | |
| |
17:30 - 19:00
FREE PAPERS - CRT | | | | | Basova V.
HOLTER MONITORING (HM) FEATURES OF PATIENTS WITH BIVENTRICULAR PACEMAKERS | |
| | | | |
| | | | Michelucci A.
ENDOTHELIAL PROGENITOR CELLS IN PATIENTS SCHEDULED FOR CARDIAC RESYNCHRONIZATION THERAPY: RELATIONSHIP WITH LEFT VENTRICULAR REMODELING AND QRS DURATION | |
| | | | |
| | | | Pieragnoli P.
IS RENAL FUNCTION "A PARTNER" ABLE TO CONDITION TAPSE CAPABILITY TO IDENTIFY RESPONDERS TO CARDIAC RESYNCHRONIZATION THERAPY? | |
| | | | |
| | | | Landolina M.
REMOTE MONITORING REDUCES HEALTHCARE UTILIZATION AND IMPROVES QUALITY OF CARE IN HEART FAILURE PATIENTS WITH IMPLANTABLE DEFIBRILLATOR: THE EVOLVO STUDY | |
| | | | |
| | | | Santini L.
IMPACT OF PREVIOUS MYOCARDIAL INFARCTION ON OUTCOMES OF CRT PATIENTS IMPLANTED WITH A QUADRIPOLAR LEFT VENTRICULAR LEAD. RESULTS FROM A MULTICENTRIC PROSPECTIVE STUDY | |
| | | | |
| |
|
| | | | |
| | | | | Room-H | 08:30 - 10:30
SURGICAL OPTIONS IN ARRHYTHMIAS TREATMENT - SESSION I - ATRIAL FIBRILLATION | | | | | Alamanni F.
The appropriate candidate for surgical therapy of atrial fibrillation | |
| | | | |
| | | | Knaut M.
Surgical tools and energy sources available | |
| | | | |
| | | | Benussi S.
Technique and results of concomitant surgical ablation of atrial fibrillation |
| | | | |
| | | | Braun J.
Techniques and results of stand-alone surgical ablation of atrial fibrillation | |
| | | | |
| | | | Pandozi C.
Hybrid endocardial - epicardial ablation of atrial fibrillation: advantages and disadvantages | |
| | | | |
| |
11:00 - 13:00
SURGICAL OPTIONS IN ARRHYTHMIAS TREATMENT - SESSION II - VENTRICULAR ARRHYTHMIAS | | | | | Grossi S.
Intraoperative endocardial and epicardial ventricular mapping |
| | | | |
| | | | Nitta T.
Surgical tools and energy sources available | |
| | | | |
| | | | Santamaria M.
Concomitant surgical ablation of ventricular tachyarrhythmias | |
| | | | |
| | | | Benussi S.
Stand-alone minitoracotomic surgical ablation of epicardial ventricular tachycardia |
| | | | |
| | | | Drago F.
Surgery to eliminate ventricular tachyarrhythmias in pediatric patients and CHD patients | |
| | | | |
| | | | Lilla della Monica P.
May heart transplantation be an alternative treatment for patients with refractory ventricular tachyarrhythmias? | |
| | | | |
| |
13:15 - 14:45
LUNCHEON PANEL - LEAD EXTRACTION. LASTEST EVOLUTION | | | | | Starck C.
Management of complications of lead extraction procedures | |
| | | | |
| | | | Mazzone P.
Transvenous lead extraction: a stepwise approach | |
| | | | |
| | | | Al Razzo O.
Lead extraction with evolution - Three years experience | |
| | | | |
| | | | Bongiorni M. G.
The internal jugular approach: when and how |
| | | | |
| |
15:00 - 17:00
TRANSCATHETER RADIOFREQUENCY ABLATION IN THE RENAL ARTERIES: A GLIMPSE INTO THE FUTURE? | | | | | Volpe M.
Rationale for radiofrequency ablation in the renal arteries | |
| | | | |
| | | | Speciale G.
Available materials and technique |
| | | | |
| | | | Hoffmann E.
Long term results and cost-benefit ratio for the treatment of resistant hypertension |
| | | | |
| | | | Schmidt M.
Selection of the optimal candidate, potential troubles and troubleshooting | |
| | | | |
| | | | Gronda E. G.
Beyond hypertension: new indications for renal denervation | |
| | | | |
| |
17:30 - 19:00
FREE PAPERS - ABLATIONS OF SUPRAVENTRICULAR TACHYARRHYTHMIAS | | | | | Yaminisharif A.
POSTEROSEPTAL ACCESSORY PATHWAY IN ASSOCIATION WITH CORONARY SINUS DIVERTICULUM: ELECTROPHYSIOLOGICAL AND ANATOMIC DESCRIPTION | |
| | | | |
| | | | Matia R.
A NEW TECHNIQUE FOR ABLATION DIFFICULT CASES OF ATRIOVENTRICULAR NODAL RE-ENTRANT TACHYCARDIA, MAPPING THE SLOW PATHWAY | |
| | | | |
| | | | Ayala Paredes F.
HIS AREA IS CLOSER THAN EXPECTED TO RF ABLATION LESIONS IN AVNR TACHYCARDIA | |
| | | | |
| | | | Grimaldi M.
THE LINEAR ABLATION CATHETER FOR THE ABLATION OF RIGHT ATRIAL FLUTTER (LINEAR LAAF-141) STUDY | |
| | | | |
| | | | Avella A.
COMMON ATRIAL FLUTTER ABLATION WITH DUTY-CYCLED RADIOFREQUENCY ENERGY: SINGLE CENTER INITIAL EXPERIENCE | |
| | | | |
| | | | Akca F.
OUTCOMES OF REPEATED CATHETER ABLATION USING MAGNETIC NAVIGATION OR CONVENTIONAL ABLATION | |
| | | | |
| |
|
| | | | |
| | | | | Room-I | 08:30 - 10:30
FREE PAPERS - NEW TECHNIQUES IN ELECTROPHYSIOLOGY AND PACING | | | | | De Ruvo E.
CONTACT FORCE IN CAVO-TRICUSPID ISTHMUS DEPENDENT ATRIAL FLUTTER ABLATION IS AFFECTED BY RESPIRATION AND VARIES FROM THE DISTAL TO THE PROXIMAL PORTION OF THE ISTHMUS | |
| | | | |
| | | | Sciarra L.
EFFICACY OF A SINGLE SHOT CRYO-ENERGY APPLICATION TO ISOLATE PULMONARY VEINS WITH A NEW CRYO-BALLOON CATHETER | |
| | | | |
| | | | De Ruvo E.
LEFT ATRIUM FAST ANATOMICAL MAPPING WITH AND WITHOUT RESPIRATORY COMPENSATION COMPARED TO ICE REAL-TIME ANATOMICAL RECONSTRUCTION | |
| | | | |
| | | | Sciarra L.
ABLATION CATHETER WITH CONTACT AND PRESSURE INFORMATION HELPS TO SIMPLIFY ATRIAL FIBRILLATION ABLATION PROCEDURES | |
| | | | |
| | | | Zoppo F.
PREDICTORS OF LEFT ATRIUM APPENDAGE CLOT DETECTION DESPITE ON-TARGET WARFARIN PREVENTION FOR ATRIAL FIBRILLATION |
| | | | |
| | | | Ricciardi D.
BRUGADA SYNDROME IN CHILDREN: ROLE OF THE HOME MONITORING SYSTEM IN ICD MANAGEMENT | |
| | | | |
| | | | Zoppo F.
RIGHT-TO-LEFT VENTRICULAR PACING-LEAD DISTANCE AND REVERSE REMODELING IN CARDIAC RESYNCHRONIZATION THERAPY. THE PREDICTIVE ROLE OF A CARDIAC BI-DIMENSIONAL (RAO/LAO) BODY SURFACE-NORMALIZED INDEX |
| | | | |
| | | | Kutarski A.
DRY PERFORATION ? THE NEW EPIDEMY OR BETTER DIAGNOSED PHENOMENON? | |
| | | | |
| |
11:00 - 13:00
FREE PAPERS - CRT OUTCOME | | | | | Zou J.
THE CHANGE OF MICROVOLT T WAVE ALTERNANS IN CARDIAC RESYNCHRONIZATION THERAPY PATIENTS | |
| | | | |
| | | | Landolina M.
IN THE REAL WORLD WOMEN BENEFIT MORE THAN MEN FROM CARDIAC RESYNCHRONIZATION THERAPY IN TERM OF LONG TERM CLINICAL OUTCOME AND POSITIVE PROGNOSIS | |
| | | | |
| | | | Lucca E.
CORRELATION BETWEEN ANTINUCLEAR ANTIBODIES (ANAS) AND ADVERSE EVENTS IN PATIENTS TREATED WITH CARDIAC RESYNCHRONIZATION THERAPY (CRT) FOR SEVERE CHF | |
| | | | |
| | | | Giammaria M.
AV AND VV INTERVAL OPTIMIZATION IN SEPTAL DEFIBRILLATION LEAD IMPLANT FOR CRTD: ECHO VS IEGM METHOD | |
| | | | |
| | | | Calovic Z.
BIVENTRICULAR PACING WITH LEFT VENTRICULAR PACING FROM A SITE OF LATE ELECTRICAL ACTIVATION IMPROVES ACUTE HEMODYNAMIC RESPONSE IN PATIENTS WITH LONG ELECTRICAL DELAY | |
| | | | |
| | | | Zanon F.
MANAGEMENT OF LATE ONSET OF PHRENIC NERVE STIMULATION IN CRT PATIENTS WITH QUADRIPOLAR LV LEAD | |
| | | | |
| | | | Bongiorni M.G.
EFFECTIVENESS OF A QUADRIPOLAR LV PACING LEAD FOR CRT: EVIDENCE FROM A 143-PATIENT MULTICENTER PROSPECTIVE REGISTRY | |
| | | | |
| | | | Mareev Y.
ACHIVEMENT OF SAME EQUALLY EFFECTIVE CARDIAC RESYNCHRONIZATION THERAPY IN PATIENTS WITH PERMANENT ATRIAL FIBRILLATION AND SINUS RHYTHM | |
| | | | |
| |
15:00 - 17:00
FREE PAPERS - ATRIAL FIBRILLATION ABLATION: LONG TERM RESULTS | | | | | Oliveira M.
LONG-TERM RESULTS OF CATHETER ABLATION FOR PAROXYSMAL AND PERSISTENT ATRIAL FIBRILLATION USING NAVX FUSION TECHNOLOGY: THE SIMPLEST IS ENOUGH | |
| | | | |
| | | | Moscoso Costa F.
LONG TERM EFFICACY OF PERCUTANEOUS ABLATION OF ATRIAL FIBRILLATION: 5 YEARS FOLLOW UP | |
| | | | |
| | | | Maglia G.
ABLATION OF PAROXYSMAL AND PERSISTENT ATRIAL FIBRILLATION WITH MULTIELECTRODE PHASED RF - DUTY CYCLED CATHETERS: LONG TERM RESULTS FROM A LARGE COHORT OF PATIENTS | |
| | | | |
| | | | Bayramova S.
GANGLIONATED PLEXI ABLATION COMBINED WITH PULMONARY VEIN ISOLATION IMPROVES OUTCOME OF CATHETER ABLATION IN PATIENTS WITH LONGSTANDING PERSISTENT ATRIAL FIBRILLATION: A P | |
| | | | |
| | | | Ferrero P.
EARLY PV ISOLATION WITH DUTY CYCLE PHASED RF CATHETER PREDICT HIGH RATE SUCCESS IN PATIENTS WITH BOTH PAROXYSMAL AND PERSISTENT AF | |
| | | | |
| | | | Ardashev A-
COMPARISON OF THE CATHETER ABLATION VS. RATE-CONTROL STRATEGY IN PATIENTS WITH CHRONIC ATRIAL FIBRILLATION: FIVE YEARS OF FOLLOW UP | |
| | | | |
| | | | Laurenzi F.
LEFT ATRIAL VOLTAGE REMODELING AND ELECTRICAL RECONNECTION AFTER PULMONARY VENOUS ISOLATION WITH DUTY-CYCLED MULTIPOLAR RADIOFREQUENCY ABLATION | |
| | | | |
| | | | Akca F.
ASSESSMENT OF CLINICAL OUTCOME OF ABLATION FOR LONG-STANDING PERSISTENT ATRIAL FIBRILLATION WITH OR WITHOUT DEFRAGMENTATION | |
| | | | |
| |
|
| | | | |
| | | | | Room-A | 08:30 - 10:30
PERMANENT CARDIAC PACING IN NEUROMEDIATED SYNCOPE | | | | | Ammirati F.
Long-term beneficial effects of permanent pacing in patients with cardioinibitory syncope | |
| | | | |
| | | | Taherpour M.
Does beta-blockers therapy increase the prophylactic power of permanent pacing in patients with neuromediated syncope? | |
| | | | |
| | | | Wolpert C.
Usefulness of data and electrograms device storage in patients with neuromediated syncope | |
| | | | |
| |
11:00 - 13:00
MRI COMPATIBLE IMPLANTABLE DEVICES | | | | | Roguin A.
When should we allow patients with non-MRI compatible implanted device to undergo MRI examination? The risk-benefit ratio | |
| | | | |
| | | | Verlato R.
MRI compatible leads, pacemakers and ICDs: are they all the same? | |
| | | | |
| | | | Roghi A.
Do we really need total body MRI compatibility? | |
| | | | |
| | | | Schwitter J.
Long term clinical experience with partial and total body MRI compatible systems |
| | | | |
| | | | Luzi M.
Long term cost-benefit ratio | |
| | | | |
| | | | Santini L.
Should MRI compatible systems be the first option for all the new implants? | |
| | | | |
| |
15:00 - 17:00
CRT AND BEYOND IN HEART FAILURE TREATMENT | | | | | Nardi S.
True LV endocardial pacing: is it possible? In which patients? | |
| | | | |
| | | | Arribas F.
CRT: are current guidelines fully adopted? | |
| | | | |
| | | | Moya A.
What the reasons for undertreatment in CRT? Which barriers should be still removed? | |
| | | | |
| | | | Singh J.P.
Beyond current guidelines: when can CRT have a role in narrow QRS? | |
| | | | |
| | | | Zanotto G.
The role of daily automatic monitoring to timely detect HF worsening | |
| | | | |
| |
17:30 - 19:00
FREE PAPERS - ARRHYTHMIAS IN CHILDREN | | | | | Rodriguez Diez G.
TWELVE YEARS OF EXPERIENCE WITH ENDOCARDIAL PACEMAKER IN CHILDREN UNDER 12 YEARS OF AGE | |
| | | | |
| | | | Al Fayyadh M.
PERMANENT PACING IN PEDIATRIC PATIENTS: SINGLE CENTER EXPERIENCE | |
| | | | |
| | | | Moscoso Costa F.
CATHETER ABLATION OF TACHYARRHYTHMIAS IN PAEDIATRIC AGE: LONG TERM FOLLOW UP |
| | | | |
| | | | Domenichini G.
THE VENTRICULAR ECTOPIC QS INTERVAL (VEQSI): DIFFERENTIATING ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY FROM RIGHT VENTRICULAR OUTFLOW TRACT ECTOPY |
| | | | |
| | | | Quesada A.
ABLATION OF RIGHT ATRIAL MACRO-REENTRANT TACHYARRHYTHMIAS AFTER SURGICAL REPAIR OF CONGENITAL AND ACQUIRED HEART DISEASE. CHARACTERISTICS AND MID-TERM FOLLOW-UP | |
| | | | |
| |
|
| | | | |
| | | | | Room-B | 08:30 - 10:30
CRYOBALLOON ABLATION OF ATRIAL FIBRILLATION - SESSION IV - FIRST OPTION THERAPY? | | | | | Koller M.
Is PVI with the cryoballoon the therapy of choice for new electrophysiologists approaching atrial fibrillation ablation? | |
| | | | |
| | | | Chierchia G. B.
Should the cryoballoon ablation of pulmonary veins be proposed as first line therapy in lone paroxysmal atrial fibrillation? | |
| | | | |
| | | | Defaye P.
Is PVI with the cryoballoon an effective strategy for persistent atrial fibrillation? | |
| | | | |
| | | | Kuck K. H.
Beyond EP: does the simplicity of balloon-based technology provide opportunities for interventional cardiologists to perform paroxysmal atrial fibrillation ablation procedures? |
| | | | |
| | | | Kuniss M.
Arctic Front in challenging anatomies: are there limitations on anatomies that can be treated? | |
| | | | |
| |
11:00 - 13:00
CRYOABLATION IN DIFFERENT CLINICAL SETTINGS | | | | | Dubuc M.
Overview of the benefits of cryothermal energy for ablation | |
| | | | |
| | | | Zardini M.
Cryoablation technology in atrio ventricular nodal re-entrant tachycardia |
| | | | |
| | | | Hidden-Lucet F.
Cryoablation technology for the treatment of Wolf Parkinson White Syndrome | |
| | | | |
| | | | Drago F.
Cryoablation technology in pediatrics patients | |
| | | | |
| | | | Bastani H.
Cryoablation technology in atrial flutter | |
| | | | |
| |
13:15 - 14:45
FREE PAPERS - CRYOABLATION OF ATRIAL FIBRILLATION | | | | | Porcellini S.
WORKING WITH FOCAL CRYOABLATION CATHETERS ONLY IS FEASIBLE AND SAFE | |
| | | | |
| | | | Maines M.
FOLLOW-UP AND PROCEDURAL DATA COMPARISON OF CRYOBALLOON ABLATION OF PULMONARY VEINS WITH AND WITHOUT ELECTROPHISIOLOGICAL VALIDATION IN PATIENTS WITH ATRIAL FIBRILLATION | |
| | | | |
| | | | Pieragnoli P.
CRYOABLATION INDUCES A TRANSIENT HYPERCOAGULABLE STATE | |
| | | | |
| | | | Mondesert B.
REDO PULMONARY VEIN ISOLATION WITH THE CRYOBALLOON. IS IT TECHNICALLY FEASIBLE AND SAFE? | |
| | | | |
| | | | Van Bracht M.
CHANGES IN ATRIAL VOLUMETRY AND FUNCTION AFTER PULMONARY VEIN ISOLATION WITH THE ARCTIC FRONT CRYO CATHETER | |
| | | | |
| |
15:00 - 17:00
CLINICAL UPDATE ON ATRIAL FIBRILLATION AND HEART FAILURE PATIENT MANAGEMENT | | | | | Santini L.
Benefits of remote control in Heart Failure Treatment: the COR HF Trial | |
| | | | |
| | | | Ziacchi M.
Efficiency of standard Bipolar Vs. Multipolar LV lead: rationale for the MORE CRT trial |
| | | | |
| | | | Pérez Pereira E.
Faster decision means Better Outcome? The REACT Study surprising results | |
| | | | |
| | | | Mantovan R.
Differences among AF ablation techniques: STAR AF II study design | |
| | | | |
| | | | Forleo G. B.
Long Term Follow Up of AF Ablation Patient: the IRON AF registry as a picture of Italian reality | |
| | | | |
| | | | Ricci R. P.
Conventional vs. Remote ICD patient management: the TARIFF study, how to obtain a proper reimbursement? |
| | | | |
| |
17:30 - 19:00
FREE PAPERS - LV PACING LEADS | | | | | Landolina M.
LONG-TERM EFFECT OF STEROID ELUTION ON THE ELECTRICAL PERFORMANCE OF CORONARY SINUS LEADS FOR CARDIAC RESYNCHRONIZATION THERAPY | |
| | | | |
| | | | Della Rocca D.G.
CLINICAL AND PROCEDURAL OUTCOME OF PATIENTS IMPLANTED WITH A QUADRIPOLAR LEFT VENTRICULAR LEAD: EARLY RESULTS OF A PROSPECTIVE MULTICENTER STUDY | |
| | | | |
| | | | Cuko A.
MULTISITE LEFT VENTRICULAR PACING IMPROVES ACUTE HEMODYNAMIC RESPONSE TO CARDIAC RESYNCHRONIZATION THERAPY IN BOTH ISCHEMIC AND NON-ISCHEMIC PATIENTS | |
| | | | |
| | | | Quirino G.
SEPTAL DEFIBRILLATION LEAD IMPLANT IN CRT DEFIBRILLATORS: MULTICENTRE DATA | |
| | | | |
| | | | Lipari A.
REIMPLANTATION OF LV LEAD AFTER EXTRACTION: WE HAVE TO DO IT, BUT WE CAN? |
| | | | |
| |
|
| | | | |
| | | | | Room-C | 08:30 - 10:30
EURO-JAPAN ARRHYTHMIA FORUM (EJAF) SESSION I - DEBATABLE SENTENCES IN THE TREATMENT OF SYNCOPE | | | | | Nogami A.
Patients with syncope and low left ventricular ejection fraction should always receive an ICD without any further investigation | |
| | | | |
| | | | Abe H.
Patients with syncope and Brugada type A ecg should receive an ICD without further investigation | |
| | | | |
| | | | Suga C.
Patients with syncope and hypertrofic cardiomyopathy should receive and ICD regardless of the wall thickness | |
| | | | |
| | | | Schilling R.
Antiarrhythmic and beta-blocking agents should be continuously administered to ICD patients affected by catecolaminergic ventricular tachycardia and syncope |
| | | | |
| | | | Kobayashi Yoshinori
Amiodarone administration should be started concomitant to ICD implantation in patients with previous traumatic syncope due to ventricular tachyarrhythmias | |
| | | | |
| | | | Ammirati F.
Patients with syncope associated to bifascicular block should be always paced without any further investigation |
| | | | |
| |
11:00 - 13:00
EURO-JAPAN ARRHYTHMIA FORUM (EJAF) SESSION II - DILEMMAS IN PREVENTION OF SUDDEN DEATH | | | | | Shoda M.
Early pacemaker implantation in congenital complete AV block in asymptomatic patients |
| | | | |
| | | | Schilling R.
Early ablation of kent bundle in asymptomatic patients |
| | | | |
| | | | Kurita T.
Direct ICD implantation in patients with Brugada typeI ecg | |
| | | | |
| | | | Shimizu W.
Direct ICD implant in patients with long QT syndrome and family history of sudden death | |
| | | | |
| | | | Matsumoto K.
Direct ICD implantation in patients with hypertrophic cardiomyopathy and family history of sudden death | |
| | | | |
| |
13:15 - 14:45
LUNCHEON PANEL - ROLE OF CARDIAC CONTRACTILITY MODULATION IN THE TREATMENT AND PREVENTION OF HEART FAILURE | | | | | Neuzil P.
Heart failure treatment: unmet clinical needs | |
| | | | |
| |
15:00 - 17:00
ABLATION AND SCD - JOINT SESSION WITH ASIA PACIFIC HEART RHYTHM SOCIETY (APHRS) | | | | | Pappone C.
Post surgical atrial arrhythmias ablation | |
| | | | |
| | | | Tilz R.
This is how I ablate difficult, complex VT in heart disease | |
| | | | |
| | | | Nogami A.
This is how I ablate difficult, complex idiopathic VT | |
| | | | |
| | | | Lo L. W.
J Wave Syndrome: where do we stand now? | |
| | | | |
| | | | Shenasa M.
The future antiarrhythmic therapy based on ICD data | |
| | | | |
| |
17:30 - 19:00
FREE PAPERS - PHYSIOLOGICAL PACING | | | | | Tanaka M.
DO PATIENTS WITH SICK SINUS SYNDROME NEED RIGHT VENTRICULAR ELECTRODES? | |
| | | | |
| | | | Giammaria M.
REAL LIFE AUTOMATIC ATRIAL CAPTURE DEVICE CONTROL | |
| | | | |
| | | | Vijayvergiya R.
A COMPARISON OF ECHOCARDIOGRAPHY AND DEVICE BASED ALGORITHM FOR A-V DELAY OPTIMIZATION IN HEART BLOCK PATIENTS | |
| | | | |
| | | | Piacenti M.
NON-INVASIVE AUTOMATIC ASSESSMENT OF THE EFFECTS OF ATRIO-VENTRICULAR DELAY CHANGES ON LEFT VENTRICULAR FILLING TIME AT DIFFERENT HEART RATES IN RESYNCHRONIZED PATIENTS | |
| | | | |
| | | | Faulknier B.
THE ASSOCIATION OF THE USE OF THE VENTRICULAR INTRINSIC PREFERENCE (VIP?) FEATURE WITH HEART FAILURE HOSPITALIZATION IN PACEMAKER PATIENTS | |
| | | | |
| | | | Stazi F.
TWO-YEAR RESULTS OF AAISSAFER STIMULATION IN MINIMIZE THE PERCENTAGE OF RIGHT VENTRICULAR PACING IN PATIENTS WITH SINUS NODE DISEASE | |
| | | | |
| |
|
| | | | |
| | | | | Room-D | 17:30 - 19:00
FREE PAPERS - PREDICTORS OF CRT RESPONSE | | | | | Sticchi E.
RELEVANCE OF RENAL FUNCTION IN EVALUATING OLD HEART FAILURE PATIENTS UNDERGOING CARDIAC RESYNCHRONIZATION THERAPY | |
| | | | |
| | | | Djordjevic-Dikic A.
ROLE OF CONTRACTILE AND CORONARY FLOW RESERVE IN PREDICTION OF RESPONSE TO CARDIAC RESYNCHRONIZATION THERAPY |
| | | | |
| | | | Vargiu S.
BASELINE MITRAL REGURGITATION GRADE PREDICT OUTCOME FOR HEART FAILURE PATIENTS TREATED WITH CARDIAC RESYNCHRONIZATION THERAPY | |
| | | | |
| | | | Perrotta L.
LEFT VENTRICULAR REVERSE REMODELING DOES NOT PREDICT OUTCOME IN ISCHEMIC HEART FAILURE PATIENTS TREATED WITH CARDIAC RESYNCHRONIZATION THERAPY | |
| | | | |
| | | | Mareev Y.
COMBINATION OF SEPTAL FLASH AND SHORT DIASTOLE TO PREDICT RESPONSE OF CARDIAC RESYNCHRONIZATION THERAPY | |
| | | | |
| | | | Villani G.Q.
INTERVENTRICULAR CONDUCTION TIME IN PREDICTING RESPONSE TO CARDIAC RESYNCHRONIZATION THERAPY | |
| | | | |
| |
|
| | | | |
| | | | | Room-E | 08:30 - 10:30
ADVANCED TECHNIQUES AND TECHNOLOGIES IN THE EP LABORATORY: WHEN AND HOW? | | | | | Kantharia B. K.
Role of intracardiac echocardiography |
| | | | |
| | | | Jais P.
Epicardial ablation of ventricular tachycardia | |
| | | | |
| | | | Lakkireddy D.
Percutaneous left atrial appendage closure |
| | | | |
| | | | Shenasa M.
Role of cardiac MRI in detection of myocardial fibrosis and its relation to ventricular arrhythmias | |
| | | | |
| |
11:00 - 13:00
TOWARDS CRT RESPONSE MAXIMIZATION - CASE BASED SESSION | | |
15:00 - 17:00
UPDATE IN CRT | | | | | Morgan J.
Do we finally have the optimal approach to left ventricular pacing? | |
| | | | |
| | | | Pisanò E. C. L.
Do we have finally achieved unbeatable data for the appropriate and non appropriate selection of candidates to CRT? | |
| | | | |
| | | | Carreras G.
Should we definitely stop to perform echocardiograms for CRT patients selection? | |
| | | | |
| | | | Haghjoo M.
Has the time-consuming programming of CRT devices a real clinical impact on quality of life and rehospitalisation? | |
| | | | |
| | | | Giannola G.
Could multipolar leads and automatic continuous programming of CRT devices solve the doctor's and patient's problems? | |
| | | | |
| |
17:30 - 19:00
FREE PAPERS - GENETICS IN ARRHYTHMIAS | | | | | Al Hassnan Z.
THE CLINICAL EXPRESSION OF LONG QT SYNDROME IN 55 INDIVIDUALS WITH KCNQ1 MUTATIONS: THE IMPACT OF CONSANGUINITY |
| | | | |
| | | | Carvalho P.
IS IT ALWAYS WORTH TO PERFORM THE SODIUM-CHANNEL BLOCKERS CHALLENGE? | |
| | | | |
| | | | Ricciardi D.
DOES HOME MONITORING IMPROVE THE MANAGEMENT OF PATIENTS WITH ARRHYTHMOGENIC CARDIAC DISEASE? RESULTS FROM A SINGLE CENTER EXPERIENCE | |
| | | | |
| |
|
| | | | |
| | | | | Room-F | 08:30 - 10:30
HEART FAILURE: EXPLORE LINKED TOPICS | | | | | Lunati M.
Vagal Stimulation is an alternative to CRT in heart failure patients | |
| | | | |
| | | | Luzi M.
Sleep disorders and CRT outcome implications | |
| | | | |
| | | | Gorenek B.
Catecholaminergic ventricular tachycardias: role and sudden cardiac death implications in heart failure | |
| | | | |
| | | | Botto G. L.
Management of diastolic heart failure: CRT can be useful? | |
| | | | |
| | | | Blanc J. J.
Incidence of renal function and glomerular filtration on CRT response: we can do more? | |
| | | | |
| | | | Gaita F.
Atrial fibrillation treatment: dedicated approaches in heart failure patients | |
| | | | |
| |
11:00 - 13:00
PHARMACOLOGICAL TREATMENT OF CARDIAC ARRHYTHMIAS | | | | | Gallagher M.M.
Amiodarone indications in ICD patients for supraventricular and ventricular tahyarrhythmias | |
| | | | |
| | | | Khan K. N.
Pill in the pocket is still a valid treatment modality for infrequent atrial fibrillation | |
| | | | |
| | | | Hasija P. K.
Amiodarone plus class IC drugs: a very efficient and safe long term prophylaxis of atrial fibrillation recurrences | |
| | | | |
| | | | Moltrasio M.
High efficacy of intravenous treatment of supraventricular tachyarrhythmias by Adenosine, Vernakalant, Ibutilide | |
| | | | |
| | | | Caravati F.
Pharmacological antiarrhythmic therapy to increase ATP efficacy in both atrial and ventricular chambers | |
| | | | |
| | | | Pezzulich B.
Upstream therapy for cardiac arrhythmias: is it obsolete? | |
| | | | |
| |
13:15 - 14:45
LUNCHEON PANEL - HAEMODYNAMIC BASED CRT OPTIMIZATION | | | | | Singh J.P.
Variability and dynamicity of optimal CRT device setting | |
| | | | |
| | | | Lunati M.
From promising CLEAR results to RESPOND-CRT trial | |
| | | | |
| | | | Leclercq C.
SonR at implant: what do we expect? |
| | | | |
| |
15:00 - 17:00
VENOUS THROMBOSIS IN DEVICE PATIENTS | | | | | Rossi S.
Subclavian vein blood flow impairment caused by pacemaker ICD leads | |
| | | | |
| | | | Forleo G. B.
Quantification of vein obstruction by flebography | |
| | | | |
| | | | Bhargava K.
Should we prophylactically anticoagulate patients with implanted devices? | |
| | | | |
| | | | Golzio P. G.
Potential problems in lead extraction in patients with venous thrombosis |
| | | | |
| | | | Mascioli G.
How to upgrade from double to triple chamber pacing a patient with venous thrombosis? | |
| | | | |
| |
17:30 - 19:00
FREE PAPERS - ICD FOLLOW-UP | | | | | Martinenghi N.
COMPARISON OF MORTALITY AND IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR THERAPY IN ELDERLY VERSUS YOUNGER ADULTS. LONG-TERM FOLLOW UP | |
| | | | |
| | | | Mora G.
MORTALITY IN PATIENTS WITH IMPLANTABLE CARDIOVERTER DEFIBRILLATOR WITH AND WITHOUT DEFIBRILLATIION THRESHOLD TESTING | |
| | | | |
| | | | Schwab J. O.
ICD SHOCKS IMPLY AN IMPORTANT IMPACT ON HOSPITALIZATIONS IN PATIENTS UNDER CRTD THERAPY (ADVANCE CRTD SUBSTUDY) | |
| | | | |
| | | | Kreuz J.
INFLUENCE OF SMOKING STATUS AND CHRONIC OBSTRUCTIVE LUNG DISEASE ON THE INCIDENCE OF APPROPRIATE ICD INTERVENTIONS IN A COLLECTIVE OF ICD RECIPIENTS WITH STRUCTURAL HEART | |
| | | | |
| | | | Grieco D.
HIGH-SENSITIVITY TROPONIN T DISCHARGE AFTER DEVICE IMPLANTATION AND DEFIBRILLATION TESTING | |
| | | | |
| | | | Varma N.
DECREASING TREND OF RIGHT VENTRICULAR PACING OVER TIME IN A LARGE COHORT OF IMPLANTABLE CARDIOVERTER DEFIBRILLATOR PATIENTS | |
| | | | |
| |
|
| | | | |
| | | | | Room-G | 08:30 - 10:30
EXPLORING THE STATE OF THE ART IN CARDIAC RESYNCHRONIZATION THERAPY | | | | | Jaswal A.
Present indications to CRT-CRTD according to the international guidelines | |
| | | | |
| | | | Vora A. M.
Advantages and disadvantages of the various approaches to the left ventricle (CS, transeptal, epicardial, etc.) | |
| | | | |
| | | | Forleo G. B.
CRT simpler implantation by multipolar left ventricular lead | |
| | | | |
| | | | Thibault B.
Remote patient management: arrhythmias and heart failure detection and alarms | |
| | | | |
| | | | Fischer A.
Remote control of myocardial ischemia in heart failure patients | |
| | | | |
| |
11:00 - 13:00
EPIDEMIOLOGY AND BURDEN OF ATRIAL FIBRILLATION: NEW ISSUES AND CHALLENGES | | | | | Capucci A.
Current Guidelines on AF: the treatment algorithm and future opportunities | |
| | | | |
| | | | Calò L.
Is there a common view for an optimal rhythm control? Key findings from the Rhythm-AF Study | |
| | | | |
| | | | Camm A. J.
Vernakalant: a new therapeutic option to increase hospital efficiency? | |
| | | | |
| |
15:00 - 17:00
ANTITACHY ATRIAL PACING TO TREAT PAROXYSMAL ATRIAL TACHYARRHYTHMIAS | | | | | Lunati M.
Incidence and type of supraventricular tachyarrhythmias in patients with implanted devices | |
| | | | |
| | | | Aliot E.
The rationale to use atrial ATP to stop paroxysmal atrial tachyarrhythmias | |
| | | | |
| | | | Landolina M.
Efficacy of atrial ATP against atrial tachyarrhythmias data from the AT 500 and Minerva trials | |
| | | | |
| | | | Capucci A.
Influence of drugs on the effects of atrial ATP | |
| | | | |
| | | | Inama G.
The optimal timing for atrial antytachy pacing | |
| | | | |
| |
17:30 - 19:00
FREE PAPERS - LEAD EXTRACTION | | | | | Domenichini G.
EVOLUTION® MECHANICAL DILATOR SHEATH AS FIRST LINE APPROACH IN COMPLEX TRANSVENOUS LEAD EXTRACTIONS: CLINICAL AND PROCEDURAL IMPACT |
| | | | |
| | | | Polewczyk A.
LATE COMPLICATIONS OF ELECTROTHERAPY-CLINICAL ANALYSIS OF INDICATIONS FOR TRANSVENOUS LEAD EXTRACTION-A SINGLE CENTER EXPERIENCE | |
| | | | |
| | | | Mascioli G.
LONG ? TERM FOLLOW-UP OF PATIENTS SUBMITTED TO LEAD EXTRACTION. EXPERIENCE OF A SINGLE CENTRE | |
| | | | |
| | | | Sohal M.
THE ROLE OF LASER LEAD EXTRACTION IN OVERCOMING VENOUS OCCLUSION DURING DEVICE UPGRADE OR REVISION | |
| | | | |
| | | | Segreti L.
TRANSVENOUS REMOVAL OF PACING AND DEFIBRILLATING LEADS: A SINGLE CENTER EXPERIENCE |
| | | | |
| | | | Vassanelli F.
SINGLE CENTRE EXPERIENCE WITH PERMANENT TRANSVENOUS LEAD EXTRACTION: ANALYSIS ON FACTORS INFLUENCING THE DIFFICULTY OF THE PROCEDURE | |
| | | | |
| |
|
| | | | |
| | | | | Room-H | 08:30 - 10:30
SURGICAL OPTIONS IN ARRHYTHMIAS TREATMENT - SESSION III - CARDIAC RESYNCHRONIZATION THERAPY | | | | | Codecasa R.
Concomitant implantation of epicardial left ventricular leads in HF patients undergoing heart surgery selection of candidates | |
| | | | |
| | | | De Paulis R.
Available surgical approaches for stand-alone left ventricular pacing: advantages and disadvantages | |
| | | | |
| | | | Tsiopoulos V.
Completely epicardial biventricular pacing: is it feasible? | |
| | | | |
| | | | Feccia M.
Left assist device and lethal ventricular arrhythmias | |
| | | | |
| |
11:00 - 13:00
SURGICAL OPTIONS IN ARRHYTHMIAS TREATMENT - SESSION IV - EARLY AND LATE ARRHYTHMIC COMORBIDITY AFTER HEART SURGERY: HOW TO AVOID, HOW TO TREAT? | | | | | Bianconi L.
Post CABG paroxysmal / persistent atrial fibrillation | |
| | | | |
| | | | Violini R.
Complete AV block post aortic valve transcatheter or surgical replacement | |
| | | | |
| | | | Pelargonio G.
Sustained ventricular tachycardia post left ventricular aneurismectomy | |
| | | | |
| | | | D'Avino E.
Supraventricular and ventricular tachyarrhythmias in the surgical Intensive Care Unit: do they affect patient outcome? | |
| | | | |
| |
13:15 - 14:45
LUNCHEON PANEL - THE SUBCUTANEOUS ICD: LATEST CLINICAL PERFORMANCE AND THE CONSEQUENCES FOR YOUR PRACTICE | | | | | Molon G.
S-ICD System overview & rationale | |
| | | | |
| | | | Boersma L. V.
Growing clinical evidence: the S-ICD System's IDE study & the EFFORTLESS registry |
| | | | |
| | | | Capucci A.
Which patients benefit most from the S-ICD System? | |
| | | | |
| | | | Calò L.
Interactive discussion based on patient cases | |
| | | | |
| |
15:00 - 17:00
ALTERNATIVE PACING SITES | | | | | Castro A.
Right ventricular outflow versus apical pacing | |
| | | | |
| | | | Zanon F.
His bundle permanent pacing still valid or obsolete? | |
| | | | |
| | | | Parisi Q.
Isolated left ventricular pacing versus biventricular pacing | |
| | | | |
| | | | Ziacchi M.
Transeptal approach for endocardial left ventricular permanent pacing |
| | | | |
| | | | Imai K.
Concomitant or stand-alone epicardial left and/or right ventricular pacing | |
| | | | |
| |
17:30 - 19:00
FREE PAPERS - RV PACING OPTIMAL SITE | | | | | Porcellini S.
CONVENTIONAL PACING AND ACCESS: IT'S TIME TO LEAVE ATRIAL APPENDAGE AND APICAL PACING | |
| | | | |
| | | | Rivera S.
RIGHT VENTRICULAR PACING: CLINICAL BENEFITS OF NON-APICAL STIMULATION | |
| | | | |
| | | | Fedorco M.
ACUTE EFFECTS OF RV PACING ON SYSTOLIC AND DIASTOLIC FUNCTION | |
| | | | |
| | | | Pastore G.
QRS MARKERS IMPROVE EFFECTIVESS RV PACING | |
| | | | |
| | | | Polewczyk A.
LEAD DEPENDENT TRICUSPID DYSFUNCTION- RETROSPECTIVE ANALYSIS OF 940 PATIENTS UNDERWENT TRANSVENOUS LEADS EXTRACTION IN SINGLE CENTER IN YEARS 2009-2011 | |
| | | | |
| |
|
| | | | |
| | | | | Room-I | 08:30 - 10:30
FREE PAPERS - ATRIAL FIBRILLATION ABLATION: FOLLOW UP | | | | | Moscoso Costa F.
CLINICAL PREDICTORS OF RECURRENCE AFTER ATRIAL FIBRILLATION ABLATION: DOES PAROXYSMAL ATRIAL FIBRILLATION RULE THE OUTCOME? |
| | | | |
| | | | Zhelyakov E.
LONG-TERM RESULTS OF EXTREMELY LONG LASTING PERSISTENT ATRIAL FIBRILLATION RADIOFREQUENCY CATHETER ABLATION | |
| | | | |
| | | | Mondesert B.
INITIAL CLINICAL EXPERIENCE WITH A DIAPHRAGMATIC ELECTROMYOGRAPHIC-GUIDED APPROACH TO MONITOR PHRENIC NERVE INTEGRITY DURING CRYOBALLOON-BASED ATRIAL FIBRILLATION ABLATIO |
| | | | |
| | | | Kurzidim K.
IMPROVING PATIENT SELECTION FOR CRYO-BALLOON ABLATION; RELATION BETWEEN PV-DIMENSIONS AND ACUTE RESPONSE IN BIG-BALLOON CRYO-ABLATION | |
| | | | |
| | | | Bordignon S.
COMPARISON OF BALLOON CATHETER ABLATION TECHNOLOGIES FOR PULMONARY VEIN ISOLATION ? THE LASER VERSUS CRYO STUDY |
| | | | |
| | | | Bayramova S.
ABLATION OF PAROXYSMAL AND PERSISTENT ATRIAL FIBRILLATION: LONG-TERM RECURRENCE RATES VIA CONTINUOUS SUBCUTANEOUS MONITORING | |
| | | | |
| | | | Bourier F.
MRI-DERIVED 3D-AUGMENTED BIPLANE FLUOROSCOPY | |
| | | | |
| |
11:00 - 13:00
FREE PAPERS - CRT RESPONSE OPTIMIZATION | | | | | Cuko A.
MULTISITE LEFT VENTRICULAR PACING IMPROVES ACUTE HEMODYNAMIC RESPONSE ASSESSED WITH PRESSURE-VOLUME LOOPS IN CARDIAC RESYNCHRONIZATION THERAPY PATIENTS | |
| | | | |
| | | | Sacchi S.
ASSESSMENT OF MYOCARDIAL CONTRACTILITY BY SONR SENSOR IN PATIENTS UNDERGOING CARDIAC RESYNCHRONIZATION THERAPY (CRT) | |
| | | | |
| | | | Ismer B.
ESOPHAGEAL LEFT HEART ELECTROGRAM TO OPTIMIZE SELECTION AND FOLLOW-UP IN CRT | |
| | | | |
| | | | Morgagni R.
EARLY CHANGES IN RIGHT HEART FUNCTION IN PATIENTS TREATED WITH CRT FOR CONGESTIVE HEART FAILURE | |
| | | | |
| | | | Orazi S.
CONTINUOUS OPTIMIZATION AND EARLY POSITIVE RESPONSE TO CRT: RESULTS FROM THE CLEAR STUDY | |
| | | | |
| | | | Rogacheva N.
INTERVENTRICULAR DELAY OPTIMIZATION: SIMULTANEOUS VS SEQUENTIONAL PACING MODE | |
| | | | |
| | | | Paoletti Perini A.
CRT-DEFIBRILLATOR LONG-TERM SURVIVAL COMPARED WITH CRT-PACEMAKER IN PATIENTS MEETING CLASS IA INDICATIONFOR CRT: DATA FROM CONTAK ITALIAN REGISTRY | |
| | | | |
| | | | Varma N.
ELECTRICAL RESYNCHRONIZATION DURING CRT USING MULTIPOLAR LV ELECTRODES | |
| | | | |
| |
15:00 - 17:00
FREE PAPERS - ATRIAL FIBRILLATION ABLATION: TECHNIQUE AND RESULTS | | | | | Partigulova A.
I.C.E. IN CATHETER ABLATION PROCEDURES. GOLD STANDARD OR SCIENTIFIC TOY? | |
| | | | |
| | | | Akca F.
RADIOFREQUENCY ABLATION AT LOW IRRIGATION FLOW RATES IS SAFER AND MORE EFFECTIVE USING A NOVEL 12-HOLES GOLD OPEN IRRIGATION CATHETER THAN A PLATINUM-IRIDIUM ELECTRODE | |
| | | | |
| | | | Forleo G.
CATHETER ABLATION OF ATRIAL FIBRILLATION GUIDED BY A 3D ELECTROANATOMICAL MAPPING SYSTEM. A 2-YEAR FOLLOW-UP STUDY FROM THE IRON-AF REGISTRY | |
| | | | |
| | | | Hummel J.
CHADS2 AND CHA2DS2VASC SCORES AS PREDICTORS OF ATRIAL FIBRILLATION ABLATION SUCCESS | |
| | | | |
| | | | Zhelyakov E.
COMPARISON OF PULMONARY VEINS ISOLATION VS LINEAR ABLATION IN PAROXYSMAL ATRIAL FIBRILLATION PATIENTS USING EITHER MATHEMATICAL SCANNING OR CLINICAL APPROACH | |
| | | | |
| | | | Strelnikov A.
GANGLIONATED PLEXI ABLATION DIRECTED BY HIGH-FREQUENCY STIMULATION AND COMPLEX FRACTIONATED ATRIAL ELECTROGRAMS FOR PAROXYSMAL ATRIAL FIBRILLATION | |
| | | | |
| | | | Esposito C.
RF ABLATION TIME REDUCTION, SAFETY AND EFFICACY FOR PULMONARY VEIN ISOLATION IN ATRIAL FIBRILLATION PROCEDURES COMPARING IRRIGATED TIP AND CONTACT FORCE SENSOR IRRIGATED CATHETER | |
| | | | |
| |
17:30 - 19:00
FREE PAPERS - PACING EPIDEMIOLOGY | | | | | Sweidan R.
DEMOGRAPHIC, CLINICAL AND DEVICE PROFILES OF 5580 PATIENTS IMPLANTED WITH IMPLANTABLE PULSE GENERATORS (IPG) IN A GEOGRAPHICALLY DIVERSE POPULATION | |
| | | | |
| | | | Vijayvergiya R.
CLINICAL AND DEMOGRAPHIC PROFILE OF PERMANENT PACEMAKER PATIENTS AT A TERTIARY CARE CENTRE IN NORTHERN INDIA | |
| | | | |
| | | | Cima A.
GENDER DISPARITIES IN THE DELIVERY OF INTERVENTIONAL CARDIAC PROCEDURES | |
| | | | |
| | | | Mugnai G.
CARDIOVASCULAR IMPLANTABLE ELECTRONIC DEVICE INFECTIONS: A 9-YEAR EXPERIENCE OF OUR CENTRE | |
| | | | |
| | | | Thibault B.
CAN-SAVER: A CANADIAN MULTI-CENTER STUDY ON SPONTANEOUS ATRIOVENTRICULAR CONDUCTION PRESERVATION | |
| | | | |
| |
|
| | | | |
|
|